Abstract
Protein tyrosine phosphatase 1B (PTP1B) is a prototype non receptor cytoplasmic PTPase enzyme that has been implicated in regulation of insulin and leptin signaling pathways. Studies on PTP1B knockout mice and PTP1B antisense treated mice suggested that inhibition of PTP1B would be an effective strategy for the treatment of type II diabetes and obesity. Here we report the X-ray structure of PTP1B in complex with compound IN1834-146C (PDB ID 4I8N). The crystals belong to P3121 space group with cell dimensions (a = b = 87.89 Å, c = 103.68 Å) diffracted to 2.5 Å. The crystal structure contained one molecule of protein in the asymmetric unit and was solved by molecular replacement method. The compound engages both catalytic site and allosteric sites of PTP1B protein. We described the molecular interaction of the compound with the active site residues of PTP1B in this crystal structure report.
Keywords: Protein tyrosine phosphatases (PTP1B), T cell PTP (TCPTP) and X-Ray Crystallography.
Protein & Peptide Letters
Title:X-Ray Structure of PTP1B in Complex with a New PTP1B Inhibitor
Volume: 21 Issue: 1
Author(s): M.V.V.V. Sekhar reddy, Chakshumathi Ghadiyaram, Sunil Kumar Panigrahi, Narasimha Rao Krishnamurthy, Subramanya Hosahalli, Arun P. Chandrasekharappa, Deepankar Manna, Sangamesh E. Badiger, Pramod K. Dubey and Lakshmi Narasu Mangamoori
Affiliation:
Keywords: Protein tyrosine phosphatases (PTP1B), T cell PTP (TCPTP) and X-Ray Crystallography.
Abstract: Protein tyrosine phosphatase 1B (PTP1B) is a prototype non receptor cytoplasmic PTPase enzyme that has been implicated in regulation of insulin and leptin signaling pathways. Studies on PTP1B knockout mice and PTP1B antisense treated mice suggested that inhibition of PTP1B would be an effective strategy for the treatment of type II diabetes and obesity. Here we report the X-ray structure of PTP1B in complex with compound IN1834-146C (PDB ID 4I8N). The crystals belong to P3121 space group with cell dimensions (a = b = 87.89 Å, c = 103.68 Å) diffracted to 2.5 Å. The crystal structure contained one molecule of protein in the asymmetric unit and was solved by molecular replacement method. The compound engages both catalytic site and allosteric sites of PTP1B protein. We described the molecular interaction of the compound with the active site residues of PTP1B in this crystal structure report.
Export Options
About this article
Cite this article as:
reddy Sekhar M.V.V.V., Ghadiyaram Chakshumathi, Panigrahi Kumar Sunil, Krishnamurthy Rao Narasimha, Hosahalli Subramanya, Chandrasekharappa P. Arun, Manna Deepankar, Badiger E. Sangamesh, Dubey K. Pramod and Mangamoori Narasu Lakshmi, X-Ray Structure of PTP1B in Complex with a New PTP1B Inhibitor, Protein & Peptide Letters 2014; 21 (1) . https://dx.doi.org/10.2174/09298665113209990089
DOI https://dx.doi.org/10.2174/09298665113209990089 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bio-Inspired Strategies against Diabetes and Associated Complications: A Review
Recent Patents on Drug Delivery & Formulation Melanocortin - 4 Receptor Agonists for the Treatment of Obesity
Current Topics in Medicinal Chemistry Adipose Tissue and Bone Marrow as Sources for Cell-based Therapeutic Angiogenesis in Ischemic Tissues: Biological Foundation and Clinical Prospects for Age-related Vascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Renal Protective Effect of Metabolic Therapy in Patients with Coronary Artery Disease and Diabetes: From Bench to Bed Side
Current Pharmaceutical Design Advancements in the Anti-Diabetes Chemotherapeutics Based on Amino Acids, Peptides, and Peptidomimetics
Mini-Reviews in Medicinal Chemistry Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular and Cellular Mechanisms of Hexavalent Chromium-Induced Lung Cancer: An Updated Perspective
Current Drug Metabolism The Use of Cyclodextrins Nanoparticles for Oral Delivery
Current Medicinal Chemistry Disorders of Mineral Metabolism in the Newborn
Current Pediatric Reviews L-/N-type Calcium Channel Blockers and Proteinuria
Current Hypertension Reviews In Silico Approach to Finding New Active Compounds from Histone Deacetylase (HDAC) Family
Current Pharmaceutical Design Efficacy of the Newest COX-2 Selective Inhibitors in Rheumatic Disease
Current Pharmaceutical Design Biomarkers of Oxidative Stress in the Assessment of Enantioselective Toxicity of Chiral Pesticides
Current Protein & Peptide Science Complications of the Type 2 Diabetes Mellitus
Current Cardiology Reviews Stage A: Can Heart Failure Be Prevented?
Current Cardiology Reviews Therapeutic Perspectives on Pancreatic Cancer
Current Cancer Drug Targets Catalytic Nanomedicine. Cu/TiO<sub>2</sub>–SiO<sub>2</sub> Nanoparticles as Treatment of Diabetic Foot Ulcer: A Case Report
Current Nanomedicine Cardioprotective Role of <i>Theobroma cacao</i> against Isoproterenol-Induced Acute Myocardial Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Post-cardiac Arrest Syndrome in Children
Current Pediatric Reviews HPA Axis Function During the Perinatal Period in Patients with Affective Disorders
Current Psychiatry Reviews